BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie Total Assets (Quarterly) : 14.25M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.25M |
| March 31, 2026 | 17.51M |
| December 31, 2025 | 22.50M |
| September 30, 2025 | 26.82M |
| June 30, 2025 | 21.56M |
| March 31, 2025 | 24.66M |
| December 31, 2024 | 25.69M |
| September 30, 2024 | 21.24M |
| June 30, 2024 | 25.21M |
| March 31, 2024 | 31.77M |
| December 31, 2023 | 21.49M |
| September 30, 2023 | 23.76M |
| June 30, 2023 | 35.10M |
| March 31, 2023 | 45.18M |
| December 31, 2022 | 47.19M |
| September 30, 2022 | 22.86M |
| June 30, 2022 | 20.11M |
| March 31, 2022 | 26.19M |
| December 31, 2021 | 31.87M |
| September 30, 2021 | 21.98M |
| June 30, 2021 | 6.047M |
| March 31, 2021 | 12.89M |
| December 31, 2020 | 13.46M |
| September 30, 2020 | 14.86M |
| June 30, 2020 | 2.084M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.309M |
| December 31, 2019 | 2.340M |
| September 30, 2019 | 2.608M |
| June 30, 2019 | 2.574M |
| March 31, 2019 | 2.964M |
| December 31, 2018 | 3.646M |
| September 30, 2018 | 4.208M |
| June 30, 2018 | 2.176M |
| March 31, 2018 | 2.215M |
| December 31, 2017 | 2.246M |
| September 30, 2017 | 2.323M |
| June 30, 2017 | 2.364M |
| March 31, 2017 | 2.462M |
| December 31, 2016 | 2.478M |
| September 30, 2016 | 2.540M |
| June 30, 2016 | 2.719M |
| March 31, 2016 | 0.2332M |
| December 31, 2015 | 0.2496M |
| September 30, 2015 | 0.266M |
| June 30, 2015 | 0.2695M |
| March 31, 2015 | 0.282M |
| December 31, 2014 | 0.2931M |
| September 30, 2014 | 0.3181M |
| June 30, 2014 | 0.3329M |
| March 31, 2014 | 0.3595M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.980M |
| Shareholders Equity (Quarterly) | 10.27M |
| Debt to Equity Ratio | 0.0268 |
| Current Ratio | 3.594 |
| Net Debt Paydown Yield | 0.12% |